Further, the five-week treatment regime by M/Lip-PTM or PTM (10 mg/kg) could also reduce steatosis and the level of TG in the livers of treated mice, while FASN in mouse livers was also significantly reduced. The gene discussed is FASN; the disease is steatosis.